Uzm. Dr. Hatice Ayyıldız Sevim

Association Between Treatment-Emergent Pancreatic Volume Loss and Survival Outcomes in Patients with Metastatic Colorectal Cancer Receiving Bevacizumab

Medicina, 2026

DOI 10.3390/medicina62081459 PMID 42654356 Açık erişimli tam metinKaynak: OpenAlex

Quality of Life and Psychological Factors in Patients with Metastatic Prostate Cancer Receiving Androgen Receptor–Targeted Therapies: A Prospective Cross-Sectional Real-World Study

Medicina, 2026

DOI 10.3390/medicina62061175 PMID 42356187 Açık erişimli tam metinKaynak: OpenAlex

Independent factors associated with advanced testicular germ cell tumors: the roles of smoking, lymphovascular invasion, and tumor size

BMC Cancer, 2026

DOI 10.1186/s12885-026-15598-y PMID 41555284 Açık erişimli tam metinKaynak: OpenAlex

Emergency Surgery Independently Predicts Postoperative Recurrence in Patients with Pathologic T3N0M0 Colon Cancer: A Retrospective Single-Center Cohort Study

Current Oncology, 2026

DOI 10.3390/curroncol33090526 PMID 42782872 Açık erişimli tam metinKaynak: OpenAlex

Quality of Life and Patient-Reported Outcomes During First-Line Chemotherapy in Older Patients with De Novo Metastatic Gastrointestinal Cancers: A Prospective Longitudinal Study

Healthcare, 2026

DOI 10.3390/healthcare14203458 PMID 42940505 Açık erişimli tam metinKaynak: ORCID

Prognostic and Treatment-Context Associations of EASIX and IPI in Extensive-Stage Small-Cell Lung Cancer Patients Receiving First-Line Therapy

Cancers, 2026

DOI 10.3390/cancers18172888 PMID 42738408 Açık erişimli tam metinKaynak: ORCID

Association of Primary Tumor Resection with Survival in De Novo Stage IV Colorectal Cancer: A Retrospective Cohort Study with Propensity Score Matching

Current Oncology, 2026

DOI 10.3390/curroncol33080467 PMID 42645372 Açık erişimli tam metinKaynak: ORCID

C-Reactive Protein–Albumin–Lymphocyte Index and the Modified Glasgow Prognostic Score as Predictors of Early Mortality After Palliative Percutaneous Transhepatic Biliary Drainage in Malignant Biliary Obstruction

Journal of Clinical Medicine, 2026

DOI 10.3390/jcm15124608 PMID 42355776 Açık erişimli tam metinKaynak: ORCID

Concomitant Metformin Use During Nivolumab Therapy for Advanced Non-Small Cell Lung Cancer: A Real-World Analysis of Survival Outcomes

Acta haematologica oncologica Turcica., 2026

DOI 10.4274/ahot.galenos.2026.2026-7-6 Açık erişimli tam metinKaynak: OpenAlex

Mean platelet volume-to-albumin ratio as a predictor of pathological complete response in HER2-positive breast cancer undergoing neoadjuvant chemotherapy

Discover Oncology, 2026

DOI 10.1007/s12672-026-04938-w PMID 41979751 Açık erişimli tam metinKaynak: OpenAlex

Comparison of Anthracycline-Containing and Anthracycline-Free Neoadjuvant Regimens in HER2-Positive Breast Cancer

Research Square, 2026

DOI 10.21203/rs.3.rs-8673435/v1 Açık erişimli tam metinKaynak: OpenAlex

Comparison of anthracycline-containing and anthracycline-free neoadjuvant regimens in HER2-positive breast cancer.

Journal of Clinical Oncology, 2026

DOI 10.1200/jco.2026.44.16_suppl.e13021 Kaynak: OpenAlex

Do Inflammatory and Nutritional Markers Predict Prognosis in Metastatic Non-Small Cell Lung Cancer Patients Receiving Nivolumab

Journal of inflammation research, 2025

DOI 10.2147/jir.s541842 PMID 41209385 4 atıf (Europe PMC) Açık erişimli tam metinKaynak: Europe PMC

Effect of treating glioblastoma with a cytokine inhibitor, ibudilast, in combination with temozolomide on survival in a patient-derived xenograft model.

Journal of Clinical Oncology, 2017

DOI 10.1200/jco.2017.35.15_suppl.2062 1 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

MIF-CD74 GUIDED THERAPEUTIC STRATEGY FOR THE UPFRONT TREATMENT OF GBM PATIENTS WITH AN UNMETHYLATED MGMT PROMOTER

Neuro-Oncology, 2014

DOI 10.1093/neuonc/nou206.15 2 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

Abstract 2844: MIF/CD74 guided therapeutic strategy for relapsed glioblastoma patients

Cancer Research, 2014

DOI 10.1158/1538-7445.am2014-2844 Kaynak: OpenAlex

Abstract 5094: Protein biomarker discovery in glioblastoma using Seldi-Tof-MS

Cancer Research, 2011

DOI 10.1158/1538-7445.am2011-5094 Kaynak: OpenAlex